Supriya Medi-Chem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -19.89%
- Ebitda -19.65%
- Net Worth -49.87%
- Total Assets -12.86%
About Supriya Medi-Chem
Supriya Medi-Chem Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 November 2011 and has a history of 13 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Smita Wagh and Satish Wagh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2011PTC224367
-
Company No.
224367
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Nov 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Supriya Medi-Chem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Wagh
|
Director | 24-Nov-2011 | Current |
|
Satish Wagh
|
Director | 24-Nov-2011 | Current |
Financial Performance of Supriya Medi-Chem.
Supriya Medi-Chem Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 19.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supriya Medi-Chem?
Unlock access to Supriya Medi-Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sachin Industries LimitedSatish Wagh is a mutual person
-
Global Gsa Services India Private LimitedSatish Wagh is a mutual person
-
Federation Of Industries Of India-TmaSatish Wagh is a mutual person
-
Basic Chemicals Cosmetics & Dyes Export Promotion CouncilSatish Wagh is a mutual person
-
Supriya Lifescience LimitedSmita Wagh and Satish Wagh are mutual person
-
Lote Industries Testing Laboratory AssociationSatish Wagh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Supriya Medi-Chem?
Unlock and access historical data on people associated with Supriya Medi-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supriya Medi-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Medi-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
